| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 550,710 | 545,490 | 555,139 | 589,279 | | Cost of Revenue | 365,482 | 369,536 | 382,010 | 408,476 | | | Gross Profit | 185,228 | 175,954 | 173,129 | 180,803 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 129,775 | 130,462 | 135,245 | 158,849 | | Non Recurring |
-
|
-
|
-
| 40,703 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 55,453 | 45,492 | 37,884 | (18,749) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 353 | 1,113 | 2,435 | 1,905 | | Earnings Before Interest And Taxes | 55,806 | 46,605 | 40,319 | (16,844) | | Interest Expense | 6,821 | 6,779 | 6,770 | 6,563 | | Income Before Tax | 48,985 | 39,826 | 33,549 | (23,407) | | Income Tax Expense | 13,832 | 11,903 | 10,238 | (15,096) | | Minority Interest | (202) |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 34,951 | 27,923 | 23,311 | (8,311) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 34,951 | 27,923 | 23,311 | (8,311) | | Preferred Stock And Other Adjustments | 157 | (157) |
-
|
-
| | | Net Income Applicable To Common Shares | $35,108 | $27,766 | $23,311 | ($8,311) |
|
0.26% Nasdaq 0.00%
Income Statement
